Woehrle, Holger
Arzt, Michael
Ficker, Joachim H.
Deger, Melike
Sterling, Kimberly L.
Ehrsam-Tosi, Daniela
Vogelmann, Tobias
Weinand, Sina
Fietze, Ingo
Young, Peter
Schoebel, Christoph
Article History
Accepted: 27 October 2023
First Online: 19 December 2023
Declarations
:
: H. Woehrle has received lecture/consulting fees from Astra Zeneca, Allergopharma, Bioprojet, Boehringer Ingelheim, Chiesi, GSK, Novartis, Inspire, Jazz and ResMed, and research support from ResMed and Novartis. M. Arzt has received grant support from ResMed, the ResMed Foundation, Philips Respironics and the Else-Kroehner Fresenisus Foundation, and lecture and/or consulting fees from ResMed, WITA Italia and Philips Respironics. J.H. Ficker has received grants and personal/lecture fees from ResMed and Inspire. AG is an employee of ResMed. M. Deger, K.L. Sterling and D. Ehrsam-Tosi are employees and shareholders of ResMed. T. Vogelmann is owner of LinkCare GmbH, which has received consulting fees from ResMed, Nyxoah and Jazz Pharmaceuticals. S. Weinand is an employee of LinkCare GmbH. I. Fietze reports support and grants from ResMed and Löwenstein Medical, personal fees from ResMed and Bioprojet, and has an unpaid role as director of the German Sleep Foundation. C. Schoebel has received grants from Astra Zeneca, ResMed and Bayer, consulting fees from ResMed, Idorsia, Bristol-Myers Squibb and Astra Zeneca, and honoraria/lecture fees from Berlin Chemie, Takeda and Mementor; he also has unpaid roles as treasurer of the German Sleep Society, head of the Telemedicine Working Group of the German Society for Internal Medicine and treasurer of the Sleep Apnea Working Group of the German Cardiac Society. F, P. Young declares that he has no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.